Latest News

This piece, as part of the 25th anniversary of the MRC CTU at UCL, explores why we established the ambitious ACORD collaboration to usher in a new era of clinical trials for neurodegenerative diseases.
The latest episode of the Trial Talk podcast focuses on the OPTIC study, which explores how patients feel about taking part in optimisation immunotherapy trials.
To help other researchers use our novel methodologies, we develop user-friendly software packages. This piece explores some examples throughout the Unit’s 25-year history.